JP2024100980A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024100980A5 JP2024100980A5 JP2024085010A JP2024085010A JP2024100980A5 JP 2024100980 A5 JP2024100980 A5 JP 2024100980A5 JP 2024085010 A JP2024085010 A JP 2024085010A JP 2024085010 A JP2024085010 A JP 2024085010A JP 2024100980 A5 JP2024100980 A5 JP 2024100980A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- postnatal
- virus
- nuclease
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000700605 Viruses Species 0.000 claims 13
- 101710163270 Nuclease Proteins 0.000 claims 9
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 6
- 210000002064 heart cell Anatomy 0.000 claims 6
- 150000007523 nucleic acids Chemical group 0.000 claims 6
- 210000000130 stem cell Anatomy 0.000 claims 6
- 210000004413 cardiac myocyte Anatomy 0.000 claims 3
- 210000003205 muscle Anatomy 0.000 claims 3
- 230000006820 DNA synthesis Effects 0.000 claims 2
- 108020005004 Guide RNA Proteins 0.000 claims 2
- 238000010459 TALEN Methods 0.000 claims 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 2
- 230000000747 cardiac effect Effects 0.000 claims 2
- 238000010362 genome editing Methods 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000002062 proliferating effect Effects 0.000 claims 2
- 230000035755 proliferation Effects 0.000 claims 2
- 210000003699 striated muscle Anatomy 0.000 claims 2
- 210000002948 striated muscle cell Anatomy 0.000 claims 2
- 230000002463 transducing effect Effects 0.000 claims 2
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims 1
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 1
- 241000649045 Adeno-associated virus 10 Species 0.000 claims 1
- 108091033409 CRISPR Proteins 0.000 claims 1
- 241000702421 Dependoparvovirus Species 0.000 claims 1
- 241000700618 Vaccinia virus Species 0.000 claims 1
- 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims 1
- 230000003511 endothelial effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 210000000663 muscle cell Anatomy 0.000 claims 1
- 210000001665 muscle stem cell Anatomy 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- 241000701161 unidentified adenovirus Species 0.000 claims 1
- 241001529453 unidentified herpesvirus Species 0.000 claims 1
- 241001430294 unidentified retrovirus Species 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862666685P | 2018-05-03 | 2018-05-03 | |
| US62/666,685 | 2018-05-03 | ||
| JP2021510297A JP7498499B2 (ja) | 2018-05-03 | 2019-05-03 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
| PCT/US2019/030748 WO2019213626A1 (en) | 2018-05-03 | 2019-05-03 | In vivo homology directed repair in heart, skeletal muscle, and muscle stem cells |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510297A Division JP7498499B2 (ja) | 2018-05-03 | 2019-05-03 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026092859A Division JP2026131720A (ja) | 2018-05-03 | 2026-06-02 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024100980A JP2024100980A (ja) | 2024-07-26 |
| JP2024100980A5 true JP2024100980A5 (enExample) | 2024-09-03 |
Family
ID=68386147
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510297A Active JP7498499B2 (ja) | 2018-05-03 | 2019-05-03 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
| JP2024085010A Pending JP2024100980A (ja) | 2018-05-03 | 2024-05-24 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510297A Active JP7498499B2 (ja) | 2018-05-03 | 2019-05-03 | 心臓、骨格筋、及び筋幹細胞におけるインビボ相同組換え修復 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210363546A1 (enExample) |
| EP (1) | EP3787692A4 (enExample) |
| JP (2) | JP7498499B2 (enExample) |
| CN (1) | CN112512595A (enExample) |
| AU (1) | AU2019262225B2 (enExample) |
| CA (1) | CA3099332A1 (enExample) |
| WO (1) | WO2019213626A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9828582B2 (en) | 2013-03-19 | 2017-11-28 | Duke University | Compositions and methods for the induction and tuning of gene expression |
| US10676726B2 (en) | 2015-02-09 | 2020-06-09 | Duke University | Compositions and methods for epigenome editing |
| US12214054B2 (en) | 2015-11-30 | 2025-02-04 | Duke University | Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use |
| EP3443081A4 (en) | 2016-04-13 | 2019-10-30 | Duke University | CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE |
| JP7490211B2 (ja) | 2016-07-19 | 2024-05-27 | デューク ユニバーシティ | Ｃｐｆ１に基づくゲノム編集の治療適用 |
| US12509492B2 (en) | 2018-01-19 | 2025-12-30 | Duke University | Genome engineering with CRISPR-Cas systems in eukaryotes |
| MX2021001850A (es) | 2018-08-18 | 2021-07-15 | Harvard College | Edicion genica in situ. |
| TWI887234B (zh) | 2019-04-14 | 2025-06-21 | 美國公爵大學 | 治療杜興氏（ｄｕｃｈｅｎｎｅ）肌肉失養症之大型突變熱點之ａａｖ載體介導之刪除 |
| EP4125349A4 (en) * | 2020-04-27 | 2024-07-10 | Duke University | GENE EDITING OF SATELLITE CELLS IN VIVO USING AAV VECTORS ENCODING MUSCLE-SPECIFIC PROMOTERS |
| CN115181722B (zh) * | 2022-08-30 | 2024-06-11 | 江苏农牧科技职业学院 | 一种鹅骨骼肌卫星细胞的体外分离和培养方法 |
| WO2024229028A2 (en) * | 2023-05-01 | 2024-11-07 | University Of Washington | Novel regulatory cassettes for specific expression of genes in muscle stem cells |
| WO2025260086A1 (en) * | 2024-06-14 | 2025-12-18 | President And Fellows Of Harvard College | In vivo site-specific base editing |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201707569YA (en) * | 2012-12-12 | 2017-10-30 | Broad Inst Inc | Delivery, Engineering and Optimization of Systems, Methods and Compositions for Sequence Manipulation and Therapeutic Applications |
| US20160058889A1 (en) * | 2014-08-11 | 2016-03-03 | The Board Of Regents Of The University Of Texas System | Prevention of muscular dystrophy by crispr/cas9-mediated gene editing |
| US20170362635A1 (en) * | 2016-06-20 | 2017-12-21 | University Of Washington | Muscle-specific crispr/cas9 editing of genes |
| CA3030587A1 (en) * | 2016-07-15 | 2018-01-18 | Salk Institute For Biological Studies | Methods and compositions for genome editing in non-dividing cells |
| WO2018058064A1 (en) * | 2016-09-23 | 2018-03-29 | Casebia Therapeutics Limited Liability Partnership | Compositions and methods for gene editing |
-
2019
- 2019-05-03 WO PCT/US2019/030748 patent/WO2019213626A1/en not_active Ceased
- 2019-05-03 EP EP19796061.0A patent/EP3787692A4/en active Pending
- 2019-05-03 CN CN201980042149.7A patent/CN112512595A/zh active Pending
- 2019-05-03 AU AU2019262225A patent/AU2019262225B2/en active Active
- 2019-05-03 US US17/052,798 patent/US20210363546A1/en active Pending
- 2019-05-03 CA CA3099332A patent/CA3099332A1/en active Pending
- 2019-05-03 JP JP2021510297A patent/JP7498499B2/ja active Active
-
2024
- 2024-05-24 JP JP2024085010A patent/JP2024100980A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522858A5 (enExample) | ||
| Müller et al. | Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors | |
| Halbert et al. | Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene | |
| JP2020522269A5 (enExample) | ||
| CN108602859B (zh) | 增强细小病毒载体递送的修饰衣壳蛋白 | |
| Ying et al. | Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library | |
| JP2021512649A5 (enExample) | ||
| Li et al. | Production and characterization of novel recombinant adeno-associated virus replicative-form genomes: a eukaryotic source of DNA for gene transfer | |
| JP2022530126A (ja) | 新規アデノ随伴ウイルス（ａａｖ）バリアント及び遺伝子治療のためのその使用 | |
| US11814642B2 (en) | Manufacturing and use of recombinant AAV vectors | |
| EP3221456A2 (en) | Genome-modified recombinant adeno-associated virus vectors | |
| JP2017510298A5 (enExample) | ||
| JP2020519284A5 (enExample) | ||
| JP2017529395A5 (enExample) | ||
| WO2020142714A1 (en) | Aav expression cassette and aav vectors comprising the same | |
| JP2020519294A5 (enExample) | ||
| CN119403823A (zh) | 具有增强的肌肉转导效率的肽修饰的aav衣壳 | |
| US20220242917A1 (en) | Compositions and methods for producing adeno-associated viral vectors | |
| Cao et al. | Replication competent helper functions for recombinant AAV vector generation | |
| US20250092391A1 (en) | Promoters for viral-based gene therapy | |
| CN118291541B (zh) | 一种诱导型启动子 | |
| JP2022523123A5 (enExample) | ||
| WO2022235970A2 (en) | Novel aav serotypes derived from a library screen | |
| CN120359235A (zh) | 用于治疗心脏病和与心脏功能障碍相关的疾病的具有降低的肝脏嗜性和增强的心脏细胞转导的重组腺相关病毒基因治疗载体 | |
| Zhao et al. | Hot topics in adeno-associated virus as a gene transfer vector |